Cleared Traditional

K093965 - ULTRAVERSE 014 AND 018 BALLOON DILATATION CATHETERS (FDA 510(k) Clearance)

Mar 2010
Decision
84d
Days
Class 2
Risk

K093965 is an FDA 510(k) clearance for the ULTRAVERSE 014 AND 018 BALLOON DILATATION CATHETERS. This device is classified as a Catheter, Angioplasty, Peripheral, Transluminal (Class II - Special Controls, product code LIT).

Submitted by C.R. Bard, Inc. (Tempe, US). The FDA issued a Cleared decision on March 17, 2010, 84 days after receiving the submission on December 23, 2009.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1250.

Submission Details

510(k) Number K093965 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 2009
Decision Date March 17, 2010
Days to Decision 84 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code LIT — Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1250

Similar Devices — LIT Catheter, Angioplasty, Peripheral, Transluminal

All 9
Armada™ 14 NC PTA Catheter
K252512 · Abbott Medical · Feb 2026
Passeo-35 Xeo Peripheral Dilatation Catheter
K250706 · Biotronik, Inc. · Apr 2025
Oscar Peripheral Multifunctional Catheter system
K241711 · Biotronik, Inc. · Jul 2024
Sterling™ MONORAIL™ PTA Balloon Dilatation Catheter (H74939031404020 )
K241683 · Boston Scientific Corporation · Jul 2024
Passeo-35 Xeo Peripheral Dilatation Catheter
K222065 · Biotronik, Inc. · Feb 2023
Highlander™ 014 PTA Balloon Dilatation Catheter
K223177 · C.R. Bard, Inc. · Jan 2023